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LXDa b s t r a c t
Antibiotic drug resistance is a serious issue for the treatment of bacterial infection. Understanding the
resistance to antibiotics is a key issue for developing new drugs. We used penicillin and sulbactam as
model antibiotics to study their interaction with model membranes. Cholesterol was used to target
the membrane for comparison with the well-known insertion model. Lamellar X-ray diffraction
(LXD) was used to determine membrane thickness using successive drug-to-lipid molar ratios. The
aspirationmethod for a single giant unilamellar vesicle (GUV)wasused tomonitor the kinetic binding
process of antibiotic–membrane interactions in an aqueous solution. Both penicillin and sulbactam
are found positioned outside the model membrane, while cholesterol inserts perpendicularly into
the hydrophobic region of themembrane in aqueous solution. This result provides structural insights
for understanding the antibiotic–membrane interaction and the mechanism of antibiotics.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Acinetobacter baumannii (A. baumannii) is an aerobic
Gram-negative bacterium that is resistant to most antibiotics
[1,2]. Since 1990s, it has been recognized as an important infec-
tious bacterium within hospitals, especially in ICUs [3,4]. A survey
conducted in 2007 by the Center for Disease Control in Taiwan
indicated that A. baumannii ranked the ﬁrst among common patho-
gens for nosocomial infections in ICUs. Developing a new type of
antibiotic is a priority for the treatment of A. baumannii infections.
There are no known antibiotics to kill A. baumannii effectively.
However, it has recently been reported that a compound, sulbac-
tam, killed A. baumannii 19606 effectively [5], but the detail mech-
anism of the bactericidal effect of sulbactam remains unclear. In
that report the authors found that when treated with sulbactam
the bacterial ATP-binding cascade (ABC) was down-regulated
which inhibited the ability of bacteria to uptake nutrients and
expel toxic material and subsequently caused bacterial death. We
compared the interactions of penicillin, sulbactam, and cholesterolwith a model membrane, giant unilamellar vesicle (GUV), by mea-
suring the changes of membrane thickness and surface area of
GUV, as well as drug-membrane kinetic binding behavior, to eluci-
date a possible structural insight for understanding the
sulbactam-membrane interaction and the mechanism of bacterici-
dal effect of sulbactam.
Penicillin is the most important antibacterial compound used
clinically [6,7] and is historically signiﬁcant because it was the ﬁrst
antibiotic that was efﬁcient for treating many bacterial infections.
The interaction between penicillin and its targeted penicillin bind-
ing proteins (PBPs) is the most typical example for elucidating the
molecular mechanism of disrupting bacterial growth by antibiotics
[8,9]. Various forms of PBP exist and bacteria usually contain many
types of PBPs within them. The most common forms of PBPs are
grouped into classes 1, 2, 3, and 4 [10,11]. Very early studies
showed that higher concentration of antibiotics caused the death
of bacteria [12] and interfered with the cell membrane synthesis
[13]. Further extensive and laborious studies in 1970s and 1980s
then established our present knowledge for the bacteria-killing
mechanism of b-lactam antibiotics. In this mechanism, the
b-lactam moiety of penicillin binds covalently with the catalytic
serine residue on the active site of PBPs [8,14,15]. PBPs are con-
stituent proteins on bacterial membranes and are involved in the
synthesis of cross-linked peptidoglycan, which is the major com-
ponent of bacterial cell walls. Penicillin binds with the
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cross-linking of peptidoglycan [16,17] and eventually leads to bac-
teria death. A recent crystal structure proved that a native form of
PBP (PBP3) becomes covalently linked to antibiotics (carbenicillin
and ceftazidime) [18]. In addition, bacteria always have higher
internal osmotic pressure than the external one [19]. It has been
reported that resisting the osmotic stress is crucial for cell growth
and division, as well as maintaining the normal cell shapes. It was
found that penicillin could be involved in the osmotic barrier and
lying close to the bacteria cell surface [20,21]. Structure defects
of peptidoglycan on bacterial cell wall would disrupt the integrity
of cell membrane and resulted in the rupture of peptidoglycan
[19]. Thus, b-lactam antibiotics such as penicillin would disrupt
the osmotic pressure and expedite bacteria death. Hence, penicillin
and derivatives have been widely used for treating hospital infec-
tions [22]. However, most bacteria soon developed
antibiotic-resistance. Sulbactam is a b-lactam analog that is typi-
cally given in combination with another antibiotics ampicillin to
form a b-lactam–b-lactamase inhibitor. Ampicillin/sulbactam is a
common penicillin-derived antibiotic that is used to treat infec-
tions caused by bacteria that are resistant to b-lactam antibiotics.
In recent years, researchers evaluated the clinical efﬁcacy of ampi-
cillin/sulbactam in the treatment of infections caused by
multidrug-resistant A. baumannii [23,24]. Currently, ampicillin/sul-
bactam is the ﬁrst-line therapy for diverse respiratory and skin
infections [25].
Here, we focused on the direct interaction between penicillin,
sulbactam and model membranes to clarify this mechanism of
inhibition of bacterial growth [5]. Cholesterol is known to interact
with membranes by inserting into their hydrophobic region to
cause membrane thickening [26–28]. Therefore, cholesterol is used
as a good model molecule for comparison with antibiotics.
In this study, we used penicillin and sulbactam as model antibi-
otics and studied their interactions with model membranes.
Cholesterol was used in the same condition for comparison.
Lamellar X-ray diffraction (LXD) was used to determine membrane
thickness. Thickness changes induced by antibiotics or cholesterol
binding to the membrane were extracted from the X-ray data. The
giant unilamellar vesicle (GUV) experiment was used to examine
the area change of a single GUV in an aqueous solution during
the entire binding process.
The structural changes induced by cholesterol partitioning into
the membrane were observed not only by LXD but also by GUV
measurements. Furthermore, sulbactam and penicillin caused
structural changes that were observed by LXD but not GUV mea-
surements. The results of this study show that cholesterol was
found perpendicularly inserted to model membrane whereas peni-
cillin and sulbactam were found positioned outside the surface of
model membrane in aqueous solution.




rhodamine B sulfonyl) (ammonium salt) (Rhod PE), and cholesterol
were purchased from Avanti Polar Lipids (Alabaster, AL). Penicillin
was purchased from YF Chemical Corp., Taiwan. Sulbactam was
purchased from TTY Biopharm, Taiwan.
2.2. Lamellar X-ray diffraction (LXD)
Sample preparation was performed as described in previous
reports [29–31]. In brief, antibiotics or cholesterol and lipids of achosen molar ratio were co-dissolved in methanol and chloroform
1:1 (v/v). A suitable amount of solution was deposited onto a clean
glass surface. The sample was vacuumed to remove the remaining
solvent and then incubated under high humidity for hydration and
rearrangement.
For lamellar X-ray diffraction measurement [30,31], the sample
was held in a temperature-humidity controlled chamber (Fig. S1
Supplementary data, schematic of chamber). The machine col-
lected at least ﬁve diffraction peaks using the h–2h reﬂectivity
mode. The 12 keV X-ray light source of BL13A at the National
Synchrotron Radiation Research Center (NSRRC) was used for the
measurements. Each h–2h scan was measured from h = 0.5 to
7.5 with a step angle of Dh = 0.001 and a 1-s exposure time per
step. Every sample was measured at near full hydration and two
lower levels of humidity for the purpose of phase determination
by the swelling method [32]. Each sample was measured twice
to conﬁrm that it was in equilibrium and to prove that it was not
damaged by X-ray radiation. X-ray diffraction was used to
construct the relative electron density proﬁle along the direction
normal to the bilayer surface to determine membrane thickness.
2.3. Giant unilamellar vesicle (GUV) aspiration method
Di22:1PC and a 1% molar ratio of the dye-labeled lipid Rhod PE
were co-dissolved in chloroform. The proper amount of solution
was deposited on an indium tin oxide coating glass (ITO glass) in
the production chamber. The steps of the GUV experiment were
described in our previous report [30]. Brieﬂy, GUVs were produced
in 100 mM sucrose solution by the electroformation method
[33–35]. Then, the isotonic glucose solution was added to the pro-
duction chamber (Fig. S2(A)) so that the molar ratio of glucose to
sucrose outside the GUVs was 3:4. A glass micropipette of
5–10 lm in diameter was used to slightly suck one selected GUV
to transfer it to the solution containing antibiotics or cholesterol
in the observation chamber (Fig. S2(B)), which was separated from
the production chamber. Because cholesterol is insoluble in water,
we dissolved cholesterol in methanol ﬁrst [36]. The protrusion of
the GUV in the glass micropipette was monitored during the entire
process of the binding of the antibiotics or cholesterol to the GUV
[30].
3. Results and discussion
3.1. Membrane-thinning effect examined by LXD
The diffraction patterns of all samples measured at 30 C and
near full hydration are shown in Fig. 1. Penicillin/sulbactam and
lipids were mixed to form solutions with P/L molar ratios of 0,
1/50, 1/15, and 1/5. Cholesterol and lipids were mixed to form
solutions with P/L molar ratios of 0, 1/50, 1/25, 1/15, 1/10, and
1/5. At least six peaks were recorded for each diffraction pattern.
No peak broadening was observed, indicating that ﬂuctuations in
the measurements were negligible. To determine the phases of
the diffraction peaks, each sample was measured in a series of low-
ering hydration levels to produce patterns at different repeating
distance D values. They were normalized relative to each other
by the Blaurock method [32] and plotted as a function of scattering
vector Q to determine the phases on the basis of the swelling
method [37–39]. A representative example is shown in Fig. 2.
After phase determination, the amplitudes of the diffraction
patterns were used to remodel the transbilayer electron density
proﬁles. The electron density proﬁles constructed from the diffrac-
tion data are shown in Fig. 3. The peak-to-peak distance (PtP) of the
trans-bilayer electron density proﬁle was deﬁned as the membrane
thickness. The previous study shows that the repeating distances of
Fig. 1. Diffraction patterns of the samples with different concentrations at 30 C
and near full hydration. (A) Penicillin was mixed with Di22:1PC bilayers at molar
ratios of 0, 1/50, 1/15, and 1/5. (B) Sulbactam was mixed with Di22:1PC bilayers at
molar ratios of 0, 1/50, 1/15, and 1/5. (C) Cholesterol was mixed with Di22:1PC
bilayers at molar ratios of 0, 1/50, 1/25, 1/15, 1/10, and 1/5. The discontinuity in the
diffraction patterns indicated by the arrow is due to the change of attenuator.
Fig. 2. Phase diagram for the X-ray diffraction of Di22:1PC containing penicillin at a
1/50 molar ratio as an example of the swelling method. The repeating distance D
was 58.6 (opened square), 59.2 (opened circle) and 60.0 (opened triangle) Å at
90.0%, 94.0% and 98.0% RH, respectively. The black curve shows Fourier-constructed
from the diffraction amplitudes measured at one humidity level. All other samples
had similar phase diagrams.
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respectively [40]. And the membrane thickness of multilamellar
vesicles (MLVs) at the excess water is about 44.3 Å. As a compar-
ison, the repeating distance and membrane thickness of our lamel-
lar sample of Di22:1PC at 98% RH are 60.7 Å and 45.0 Å. The
repeating distance is 10 Å smaller than the ones at full hydration
and excess water but the membrane thickness is comparable.
The structure change from near full hydration (98% RH) to excesswater is to increase the thickness of water layer. Fig. 4 shows the
PtP versus the concentration of antibiotics and cholesterol. For
penicillin-to-lipid and sulbactam-to-lipid, the phosphate
peak-to-phosphate peak distance (PtP) decreased with increasing
P/L molar ratios. The observed bilayer thinning in reverse propor-
tion to P/L was consistent with the antibiotic molecules being
embedded in the headgroup region of the membrane surface. The
area of expansion was generated by the displacement of water
molecules during the embedding of the antibiotic molecules in
the headgroup region of the membrane surface. In contrast, for
cholesterol-to-lipid, the phosphate peak-to-phosphate peak dis-
tance (PtP) increased with increasing P/L molar ratios, indicating
that cholesterol inserted into the membrane in a manner that
decreased lipid area as the number of inserted cholesterol mole-
cules increased.
Fig. 4 shows that the phosphate-to-phosphate distance (PtP) of
di22:1PC decreased from 44.9 Å to 42.1 Å with a 0.2
penicillin-to-lipid molar ratio and from 44.9 Å to 43.5 Å with a
sulbactam-to-lipid molar ratio of 0.2. In both cases, the PtP dis-
tance decreased linearly as the drug concentrations increased. In
contrast, when the multilamellar bilayer was mixed with a solu-
tion with a cholesterol-to-lipid molar ratio of 0.2, the PtP distance
increased to 46.1 Å. This indicated that the interactions of the
antibiotics and cholesterol with the multilamellar bilayer were dif-
ferent. Our previous reports indicated that cholesterol molecules
inserted into the lipid bilayer [41,42] and increased the PtP dis-
tance [43]. Other studies by us also indicated that peptides lay hor-
izontally on the membrane outer surface, which shortens the PtP
distance [44,45]. Similarly, Fig. 4 conﬁrms that penicillin and sul-
bactam both lay horizontally outside the bilayer surface. Thus,
penicillin and sulbactam do not tend to enter into bacterial cell
walls. A recent report showed that sulbactam killed A. baumannii
by inhibiting bacterial ABC transporters [5]. Thus, penicillin and
sulbactam very likely exert their bactericidal effects at the cell
wall. This result is consistent with the fact that penicillin binds
to the polysaccharide chain of the bacterial cell wall [16,46].
The mechanism of peptide-induced membrane thinning was
investigated in a previous study [45]. To recognize the interaction
between antibiotics and the membrane, we used the same
approach as was used previously to quantitatively analyze our
Fig. 3. Electron density proﬁles of pure Di22:1PC and antibiotics or cholesterol in
Di22:1PC at various molar ratios. (A) Penicillin was mixed with Di22:1PC bilayers at
molar ratios of 0, 1/50, 1/15, and 1/5. (B) Sulbactam was mixed with Di22:1PC
bilayers at molar ratios of 0, 1/50, 1/15, and 1/5. (C) Cholesterol was mixed with
Di22:1PC bilayers at molar ratios of 0, 1/50, 1/25, 1/15, 1/10, and 1/5. The proﬁles
were not normalized and were displaced for clarity. The short vertical bars indicate
the positions of the peaks.
Fig. 4. Membrane thicknesses (PtP) determined by X-ray diffraction change with
penicillin, sulbactam, and cholesterol concentrations. The Di22:1PC bilayers were
mixed with penicillin (opened square) and sulbactam (opened circle) at molar
ratios of 0, 1/50, 1/15, and 1/5 and with cholesterol (opened triangle) at molar ratios
of 0, 1/50, 1/25, 1/15, 1/10, and 1/5. The error bars are determined from the average
of more than three repeated measurements.
Fig. 5. The normalized area expansion, DA/A, versus the concentration of penicillin
(square) or sulbactam (circle). DA/A is equal to Dh/h, as calculated from Fig. 1
using the relation h = PtP  10 Å. The dashed lines indicate the linear ﬁtting of the
data.
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region of the lipid bilayer, we were able calculate the normalized
area expansion by the relation, Dh/h =DA/A, where h is the thick-
ness of the hydrophobic region and A is the membrane area. The h
value was determined by subtracting twice the length of the glyc-
erol region, i.e., 10 Å, from the PtP [47,48]. With the assumption
that the area expansion was due to the partitioning of theantibiotics into the interface of the lipid bilayer, the following
equation was used: DA/A  (Na/Nl)Aa/Al, where (Na/Nl) is the
antibiotic-to-lipid molar ratio deﬁned as the concentration of
antibiotic, Aa is the area of expansion induced by one antibiotic
and Al is the cross-sectional area of the lipids. Fig. 5 shows DA/A
vs. concentration of antibiotic, and the data presented in Fig. 5
was converted from the data presented in Fig. 4. Using
Al  69.3 Å2 and the slopes of linear ﬁtting in Fig. 5, we obtained
Aa values of 26.9 ± 1.5 Å2 and 16.5 ± 2.1 Å2 for penicillin and sul-
bactam, respectively. The molecular sizes of penicillin and sulbac-
tam are 6.1 Å * 4.5 Å * 11.2 Å and 7.0 Å * 4.5 Å * 8.2 Å. The larger Aa
value found for penicillin was most likely due its larger molecular
size. Furthermore, the antibiotics need to remove water molecules
around the headgroups of lipid and then pull the headgroups away
to case the area expansion. We deduced the simple relation accord-
ing to the geometrical argument: Ra = Aa + Aw. Here Ra is the
cross-sectional area of antibiotics, Aa is the area expansion induced
by one antibiotic binding and Aw is the area occupied by the water
Fig. 6. Time evolution ﬂuorescence images of GUVs exposed to penicillin, sulbactam, and cholesterol. The typical GUV diameter (DV) is 35–50 lm. The inner diameter of the
pipette (DP) is 7–10 lm. GUVs are exposed to solutions with (A) 1.72  103 M penicillin (B) 1.11  103 M sulbactam and (C) 5.56  105 M cholesterol. The scale bar in the
image is 20 lm.
Fig. 7. Concentration dependence of the normalized area expansion induced by (A) penicillin and sulbactam or (B) cholesterol at t = 540 s. After an exposure time of 540 s, the
area expansions are saturated and no longer change in all cases. The error bars are determined from the average of more than three repeated measurements.
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range, the area occupied by the water molecules per lipid is about
10 Å2 [49] and there are approximately 2–4 lipids surrounding one
antibiotic. Thus Aw is approximately 20–40 Å2 for one binding
penicillin and sulbactam. The Ra of penicillin and sulbactam are
47–67 Å2 and 37–57 Å2 respectively. The above quantitative analy-
sis conﬁrms that penicillin and sulbactam both lay horizontally on
the interface of bilayer, again (Fig. S3).
3.2. Aspiration method for GUV
The aspiration method for GUV was developed by E. Evan and
used to determine the elasticity of a membrane [50,51]. Our pre-
vious studies [30,52] applied this method to the measurement ofthe area expansion induced by peptide binding to a membrane.
When the volume of a GUV is constant [53], the increase in the
aspirated projection length LP inside the micropipette, DLP, can
be converted to area expansion, DA, by the following approximate
relation: DLP: DA = pDP (1  DP/DV) DLP [51]. DP and DV are the
inner diameter of the micropipette and the diameter of the
GUV, respectively. The increase in the aspirated projection length
LP inside the micropipette provides a direct measurement of the
membrane area expansion induced by drug or cholesterol bind-
ing. Fig. 6 shows the time evolution ﬂuorescence images of GUV
interacting with penicillin, sulbactam, and cholesterol. We calcu-
lated the normalized area expansion, DA/A, from the images using
the geometrical relation mentioned above. The normalized area
expansions, DA/A, of a GUV exposed to antibiotics and cholesterol
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trations were measured 3–5 times to determine the statistical
average. There is no signiﬁcant change in area for a GUV exposed
to penicillin or sulbactam. Combined the results of X-ray diffrac-
tion and GUV experiment, antibiotics target to membranes but
don’t cause area expansion, i.e. Aa  0. The area occupied by the
water molecules around the headgroup of lipid (Aw) in the excess
water is much larger than in near full hydration so that Aa  0.
Conversely, the percentage of expansion of the area of a GUV
exposed to high-concentration cholesterol solutions is 2%. In the
GUV system, there are two competitive effects on the change in
area. One is the ‘‘condensing effect’’ on lipid cross-sectional area,
which decreases the area of the membrane in the presence of low
cholesterol concentrations and achieves saturation in the pres-
ence of high cholesterol concentrations [43]. The other effect is
the ‘‘insertion effect’’ on total membrane area, which increases
the membrane area as the number of inserted cholesterols
increases. Consequently, the two effects cancel out in the pres-
ence of low cholesterol concentrations, and the insertion effect
dominates the change in area in the presence of high cholesterol
concentrations. The cholesterol induced effects on membrane
area we observed in this study is agree with the previous report
[54].4. Conclusions
Our previous study showed that the protein expression of ABC
transporter was decreased after treating A. baumannii with sulbac-
tam [5]. The biological function of ABC transporter is to import
nutrient into the bacteria and also to export toxic material. We
compared the protein sequences of transpeptidase domain of peni-
cillin binding proteins (PBP) 1a, 1b (class A), and 2, 3 (class B), with
the ATPase and permease components (APC) of ABC transporter of
A. baumannii. Table S1 shows the sequence alignment of these four
transpeptidases of PBPs and APC. As can be seen, the homology
within PBPs is greater, whereas with APC the homology is poor.
Further quantitative analysis is shown in Table S2. ClustalW
score indicated the close genetic relationship between PBP 1a
and 1b, score 36.26; PBP 2 and 3, score 28.67. On the contrary,
APC shows poor genetic relationship with PBP 1a, 1b, 2, and 3, with
scores ranging from 2.17 to 8.79, all less than 10. A genetic phylo-
gram and distance between the protein sequences is also shown in
Table S2. In this phylogram, the transpeptidase domain of PBP 1a
and 1b, PBP 2 and 3 are each genetically related, whereas APC
domain of ABC transporter is not related with PBPs.
In summary, the bactericidal effect of sulbactam against A. bau-
mannii involves down-regulating the ABC transporter [5].
According to the protein sequence and phylographic analyses,
ATPase and permease components, the active site of ABC trans-
porter, has low relationship with the transpeptidase domain of
PBP classes. Therefore, the mechanism of the bactericidal effect
of sulbactam against A. baumannii is different from that of peni-
cillin (with penicillin binding proteins). The bactericidal effect of
sulbactam against A. baumannii is a new phenomenon.
On the other hand, we studied the interaction between antibi-
otics and membranes using not only X-ray diffraction in equilib-
rium but also kinetic experiments involving a single GUV in
solution. The result of X-ray diffraction indicates penicillin and sul-
bactam target to membrane and lay horizontally on the interface of
bilayer rather than insert into membrane like cholesterol. The GUV
experiment suggests that neither penicillin nor sulbactam is able
to disturb the structure of membrane and that cholesterol inserts
perpendicularly into a membrane in an aqueous solution. The less
perturbation means less deformation energy cost of
antibiotic-membrane binding. Due to the hydrophobic interaction,penicillin and sulbactam prefer to bind on membrane rather dis-
solve in the solution. It implies that the antibiotics have more
chances to ‘‘meet’’ the receptor protein or disturb the osmotic pres-
sure to kill the bacteria. The hypothesis provides the new insight
on the membrane mediated enhancement of bacteria inhibition.
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